These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27580904)

  • 1. Immunological processes related to cognitive impairment in MS.
    Berger T
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():34-8. PubMed ID: 27580904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research.
    Grzegorski T; Losy J
    Rev Neurosci; 2017 Nov; 28(8):845-860. PubMed ID: 28787275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Impairment in Multiple Sclerosis.
    Trenova AG; Slavov GS; Manova MG; Aksentieva JB; Miteva LD; Stanilova SA
    Folia Med (Plovdiv); 2016 Sep; 58(3):157-163. PubMed ID: 27760012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features.
    Ekmekci O
    Behav Neurol; 2017; 2017():1463570. PubMed ID: 29434433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking Cognitive Impairment to Neuroinflammation in Multiple Sclerosis using neuroimaging tools.
    Barros C; Fernandes A
    Mult Scler Relat Disord; 2021 Jan; 47():102622. PubMed ID: 33227630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis.
    Miller E; Morel A; Redlicka J; Miller I; Saluk J
    Curr Neuropharmacol; 2018; 16(4):475-483. PubMed ID: 29119933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?
    Stojić-Vukanić Z; Hadžibegović S; Nicole O; Nacka-Aleksić M; Leštarević S; Leposavić G
    Front Immunol; 2020; 11():566225. PubMed ID: 33329528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
    Korakas N; Tsolaki M
    Cogn Behav Neurol; 2016 Jun; 29(2):55-67. PubMed ID: 27336803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative evidence for MS as a neural network disconnection syndrome consistent with cognitive impairment mechanisms and the confounding role of fatigue and depression-outlook from the Fourth Nordic MS symposium.
    van Ettinger-Veenstra H
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():4-7. PubMed ID: 27580899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional MRI in investigating cognitive impairment in multiple sclerosis.
    Rocca MA; De Meo E; Filippi M
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():39-46. PubMed ID: 27580905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis, discerning depression from cognition.
    Portaccio E
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():14-8. PubMed ID: 27580901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effects of high-education levels on cognition in different stages of multiple sclerosis.
    Rimkus CM; Avolio IMB; Miotto EC; Pereira SA; Mendes MF; Callegaro D; Leite CDC
    Mult Scler Relat Disord; 2018 May; 22():41-48. PubMed ID: 29554549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in MS: rehabilitation approaches.
    Hämäläinen P; Rosti-Otajärvi E
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():8-13. PubMed ID: 27580900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise as a Countermeasure to Declining Central Nervous System Function in Multiple Sclerosis.
    Motl RW; Sandroff BM
    Clin Ther; 2018 Jan; 40(1):16-25. PubMed ID: 29287750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between depression and cognitive decline in sclerosis multiplex patients].
    Hegedüs K; Kárpáti J; Szombathelyi É; Simó M
    Neuropsychopharmacol Hung; 2015 Mar; 17(1):31-6. PubMed ID: 25935381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
    Guenter W; Jabłońska J; Bieliński M; Borkowska A
    Psychiatr Pol; 2015; 49(5):897-910. PubMed ID: 26688841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can fibrinolytic system components explain cognitive impairment in multiple sclerosis?
    Pérez-Martín MY; González-Platas M; Jiménez-Sosa A; Plata-Bello J; Carrillo-Padilla FJ; Franco-Maside A; Eguia-Del Río P
    J Neurol Sci; 2017 Nov; 382():66-72. PubMed ID: 29111023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective personality traits: High openness and low neuroticism linked to better memory in multiple sclerosis.
    Leavitt VM; Buyukturkoglu K; Inglese M; Sumowski JF
    Mult Scler; 2017 Nov; 23(13):1786-1790. PubMed ID: 28067603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.